- Home
- PTGX vs TAC Comparison
PTGX vs TAC Comparison
Compare PTGX & TAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- TAC
- Stock Information
- Founded
- PTGX 2006
- TAC 1909
- Country
- PTGX United States
- TAC Canada
- Employees
- PTGX N/A
- TAC N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- TAC Electric Utilities: Central
- Sector
- PTGX Health Care
- TAC Utilities
- Exchange
- PTGX Nasdaq
- TAC Nasdaq
- Market Cap
- PTGX 2.9B
- TAC 2.9B
- IPO Year
- PTGX 2016
- TAC N/A
- Fundamental
- Price
- PTGX $51.39
- TAC $10.78
- Analyst Decision
- PTGX Strong Buy
- TAC Buy
- Analyst Count
- PTGX 9
- TAC 2
- Target Price
- PTGX $67.11
- TAC $19.75
- AVG Volume (30 Days)
- PTGX 1.0M
- TAC 1.8M
- Earning Date
- PTGX 08-05-2025
- TAC 07-31-2025
- Dividend Yield
- PTGX N/A
- TAC 1.62%
- EPS Growth
- PTGX N/A
- TAC N/A
- EPS
- PTGX 0.86
- TAC 0.00
- Revenue
- PTGX $207,801,000.00
- TAC $1,847,844,992.00
- Revenue This Year
- PTGX N/A
- TAC N/A
- Revenue Next Year
- PTGX $47.15
- TAC N/A
- P/E Ratio
- PTGX $64.57
- TAC $4,674.85
- Revenue Growth
- PTGX N/A
- TAC N/A
- 52 Week Low
- PTGX $32.50
- TAC $6.78
- 52 Week High
- PTGX $60.60
- TAC $14.64
- Technical
- Relative Strength Index (RSI)
- PTGX 61.93
- TAC 56.88
- Support Level
- PTGX $52.16
- TAC $10.56
- Resistance Level
- PTGX $57.24
- TAC $10.91
- Average True Range (ATR)
- PTGX 1.71
- TAC 0.32
- MACD
- PTGX -0.25
- TAC -0.09
- Stochastic Oscillator
- PTGX 55.96
- TAC 38.33
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About TAC TransAlta Corporation
TransAlta Corp is an independent power producer based in Alberta, Canada. The company operates a diverse and growing fleet of electrical power generation assets in Canada, the United States, and Australia. The company has six reportable segments namely, Hydro, Wind & Solar, Energy Marketing, Gas, Energy Transition segment and Corporate Segment. The company generates the majority of its revenue from the gas segment.